BCRX

BioCryst Pharmaceuticals, Inc. Competitors

$1.71
*  
0.08
  negative  
4.47%
Get BCRX Alerts
*Delayed - data as of Jun. 19, 2013 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

 Save stocks for next time
 | Sponsored

Competitor Industry: Biotechnology: Biological Products (No Diagnostic Substances)

BioCryst Pharmaceuticals, Inc.
CompanyName
Symbol: Market
LastSale NetChange Volume Today's High/ Low 52 Weeks High/ Low P/ERatio Market Cap
Gilead Sciences, Inc.
GILD: NASDAQ-GS
$ 50.60 -1.34   6,396,675 $ 52.05
$ 50.57
$ 58.065
$ 24.80
28.35 77,033,085,800
Amgen Inc.
AMGN: NASDAQ-GS
$ 99.18 -2.32   3,825,420 $ 102
$ 99.15
$ 114.95
$ 70.88
16.78 74,229,287,400
Life Technologies Corporation
LIFE: NASDAQ-GS
$ 74.21 -0.06   1,765,179 $ 74.27
$ 74.06
$ 74.48
$ 40.50
31.44 12,644,419,270
ARIAD Pharmaceuticals, Inc.
ARIA: NASDAQ-GS
$ 17.22 -0.57   1,459,683 $ 18.02
$ 17.20
$ 25.40
$ 15.35
NE 3,163,021,260
NPS Pharmaceuticals, Inc.
NPSP: NASDAQ-GM
$ 14.76 -0.57   1,366,242 $ 15.37
$ 14.56
$ 16.47
$ 6.77
NE 1,480,915,080
Protalix BioTherapeutics, Inc.
PLX: AMEX
$ 5.23 0.15   1,310,048 $ 5.45
$ 5.10
$ 6.80
$ 4.71
NE 489,020,690
PDL BioPharma, Inc.
PDLI: NASDAQ-GS
$ 7.69 -0.23   1,265,118 $ 7.94
$ 7.68
$ 8.475
$ 6.32
4.99 1,076,084,770
Biogen Idec Inc.
BIIB: NASDAQ-GS
$ 203.80 -7.00   1,212,682 $ 211.26
$ 203.59
$ 242.64
$ 134
32.35 48,160,385,600
Halozyme Therapeutics, Inc.
HALO: NASDAQ-GS
$ 6.32 -0.09   969,544 $ 6.55
$ 6.31
$ 9.92
$ 3.86
NE 712,295,600
ONYX Pharmaceuticals, Inc.
ONXX: NASDAQ-GS
$ 85.54 -3.26   960,163 $ 88.80
$ 85.45
$ 101.569
$ 44
NE 6,159,393,240
Vical Incorporated
VICL: NASDAQ-GS
$ 3.11 0.03   927,844 $ 3.17
$ 3.10
$ 4.74
$ 2.61
NE 268,231,280
Chelsea Therapeutics International, Ltd.
CHTP: NASDAQ-CM
$ 2.29 -0.16   864,766 $ 2.44
$ 2.22
$ 2.76
$ .70
NE 153,523,890
Repros Therapeutics Inc.
RPRX: NASDAQ-CM
$ 19.20 0.01   748,088 $ 21.02
$ 19
$ 20.78
$ 7.795
NE 328,627,200
Neurocrine Biosciences, Inc.
NBIX: NASDAQ-GS
$ 12.88 0.18   706,651 $ 13.35
$ 12.82
$ 14.06
$ 6.72
NE 856,635,920
StemCells, Inc.
STEM: NASDAQ-CM
$ 1.68 -0.09   687,939 $ 1.79
$ 1.68
$ 2.67
$ .621
NE 62,899,200
Idera Pharmaceuticals, Inc.
IDRA: NASDAQ-CM
$ .68 -0.06   621,971 $ .75
$ .68
$ 1.22
$ .1866
NE 30,710,840
Cel-Sci Corporation
CVM: AMEX
$ .24 0.00   612,253 $ .245
$ .24
$ .4674
$ .205
NE 74,216,160
Qiagen N.V.
QGEN: NASDAQ-GS
$ 19.50 -0.12   560,697 $ 19.85
$ 19.50
$ 22.20
$ 15.90
39 4,611,496,500
BioCryst Pharmaceuticals, Inc.
BCRX: NASDAQ-GS
$ 1.71 -0.08   477,614 $ 1.80
$ 1.70
$ 4.95
$ 1.08
NE 87,004,800
Novavax, Inc.
NVAX: NASDAQ-GS
$ 1.89 -0.04   462,787 $ 1.92
$ 1.89
$ 2.77
$ 1.23
NE 279,608,490
Seattle Genetics, Inc.
SGEN: NASDAQ-GS
$ 31.49 -0.71   399,901 $ 32.40
$ 31.37
$ 39
$ 21.05
NE 3,792,592,620
Sangamo BioSciences, Inc.
SGMO: NASDAQ-GS
$ 7.93 -0.25   398,014 $ 8.25
$ 7.86
$ 11.24
$ 4.77
NE 423,089,290
Hemispherx BioPharma, Inc.
HEB: AMEX
$ .247 0.00   387,915 $ .2501
$ .24
$ 1.10
$ .18
NE 41,305,810
Agenus Inc.
AGEN: NASDAQ-CM
$ 3.98 0.20   373,191 $ 4.05
$ 3.71
$ 5.47
$ 3.37
NE 110,858,920
Acorda Therapeutics, Inc.
ACOR: NASDAQ-GS
$ 34.84 -0.11   291,593 $ 35.36
$ 34.684
$ 40.87
$ 21.33
9.7 1,403,355,200